Download PDF
Am J Perinatol 2004; 21(6): 347-353
DOI: 10.1055/s-2004-831879
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Severe Cardiotocographic Pathology at Labor: Effect of Acute Intravenous Tocolysis

Outi Palomäki1 , Miia Jansson2 , Heini Huhtala2 , Pertti Kirkinen1
  • 1Department of Obstetrics and Gynecology, Tampere University Hospital, Finland
  • 2University of Tampere, Finland
Further Information

Publication History

Publication Date:
16 August 2004 (online)

    Permissions and Reprints

The purpose of this study was to evaluate the effect of acute tocolysis on severely pathological cardiotocographic (CTG) readings during the first stage of labor. Seventy-three consecutive parturients with full-term pregnancy were treated by acute tocolysis with a β-mimetic agent after recognition of severe CTG abnormality in the first stage of labor. The main outcome measures were normalization or persistence of the CTG pattern after tocolysis. Risk factors with regard to CTG effect of tocolysis were also evaluated. In 67% of cases the CTG pattern normalized at a mean of 4 minutes after the beginning of intravenous tocolysis. No characteristic feature of the parturient, labor course, CTG abnormality, or the parameters of uterine contractive activity was found to be a predictive factor with regard to the CTG effect of tocolysis. No adverse effects of tocolytic therapy were found. Tocolysis with a β-mimetic agent is an effective method to normalize the CTG pattern during the first stage of labor, even in cases without uterine hypertonicity.

KEYWORDS

Tocolysis - labor - β-mimetic agent - CTG abnormality

REFERENCES

  • 1 American College of Obstetricians and Gynecologists . Fetal heart rate patterns: monitoring, interpretation and management. ACOG technical bulletin 207.  Int J Gynaecol Obstet. 1995;  51 65-74
    CrossrefPubMedGoogle Scholar
  • 2 Luzietti R, Erkkola R, Hasbargen U, Mattson L A, Thoulon J M, Rosen K G. European Community Multi-center Trial “Fetal ECG Analysis During Labor”: ST plus CTG analysis.  J Perinat Med. 1999;  27 431-440
    CrossrefPubMedGoogle Scholar
  • 3 Rosen K G, Luzietti R. The fetal electrocardiogram: ST waveform analysis during labour.  J Perinat Med. 1994;  22 501-512
    PubMedGoogle Scholar
  • 4 Huddleston J F. Intrapartum fetal assessment.  Clin Perinatol. 1999;  26 549-568
    PubMedGoogle Scholar
  • 5 Hendrix N W, Chauhan S P, Scardo J A, Ellings J M, Devoe L D. Managing nonreassuring fetal heart rate patterns before cesarean delivery.  J Reprod Med. 2000;  45 995-999
    PubMedGoogle Scholar
  • 6 Gamissans O, Esteban-Altirriba J, Calaf J. The treatment of intrapartum fetal acidosis by intravenous infusion of β-adrenergic drugs to the mother. In: Proceedings of the 2nd European Congress on Perinatal Medicine London; 1970 Basel: Karger 1971: 152-160
    Google Scholar
  • 7 Ingemarsson I, Ingemarsson E. Variabla decelerationer [Variable decelerations] (in Swedish). In: Elektronisk fosterövervakning Lund; Studentlitteratur 1987: 161-190
    Google Scholar
  • 8 Cabero L, Vaz-Romero M, Cerqueira M J, Bellart J, Duran-Sanchez P, Esteban-Altirriba J. Conservative treatment of intrapartum fetal acidosis with a betamimetic agent.  Eur J Obstet Gynecol Reprod Biol. 1988;  28 185-190
    CrossrefPubMedGoogle Scholar
  • 9 Kulier R, Hofmeyr G. Tocolytics for suspected intrapartum fetal distress.  Cochrane Database Syst Rev. 2000;  2 CD000035
    PubMedGoogle Scholar
  • 10 Kulier R, Gülmezoglu A M, Hofmeyr G J, Van Gelderen C J. Betamimetics in fetal distress: a randomized controlled trial.  J Perinat Med. 1997;  25 97-100
    PubMedGoogle Scholar
  • 11 Gummerus M. Subpartale Tokolyse bei fetalen Notsituationen [Management of intrapartum fetal distress] (in German with English abstract.)  Z Geburtshilfe Perinatol. 1982;  186 249-255
    PubMedGoogle Scholar
  • 12 Ingemarsson I, Arulkumaran S, Ratnam S S. Single injection of terbutaline in term labor. Effect on fetal pH in cases with prolonged bradycardia.  Am J Obstet Gynecol. 1985;  153 859-864
    PubMedGoogle Scholar
  • 13 Burke M S, Porreco R P, Day D et al.. Intrauterine resuscitation with tocolysis. An alternate month clinical trial.  J Perinatol. 1989;  9 296-300
    PubMedGoogle Scholar
  • 14 Mendez-Bauer C, Shekarloo A, Cook V, Freese U. Treatment of acute intrapartum fetal distress by β2-sympathomimetics.  Am J Obstet Gynecol. 1987;  156 638-642
    PubMedGoogle Scholar
  • 15 Caritis S N, Lin L S, Wong L K. Evaluation of the pharmacodynamics and pharmacokinetics of ritodrine when administered as a loading dose. On establishing a potentially useful drug administration regimen in cases of fetal distress.  Am J Obstet Gynecol. 1985;  152 1026-1031
    PubMedGoogle Scholar
  • 16 Gerris J, Thiery M, Bogaert M, De Schaepdryver A. Randomized trial of two beta-mimetic drugs (ritodrine and fenoterol) in acute intra-partum tocolysis.  Eur J Clin Pharmacol. 1980;  18 443-448
    CrossrefPubMedGoogle Scholar
  • 17 Shekarloo A, Mendez-Bauer C, Cook V, Freese U. Terbutaline (intravenous bolus) for the treatment of acute intrapartum fetal distress.  Am J Obstet Gynecol. 1989;  160 615-618
    PubMedGoogle Scholar
  • 18 Patriarco M S, Viechinicki B M, Hutchinson T A, Klasko S K, Yeh S Y. A study on intrauterine fetal resuscitation with terbutaline.  Am J Obstet Gynecol. 1987;  157 384-387
    PubMedGoogle Scholar
  • 19 Axemo P, Fu X, Lindberg B, Ulmsten U, Wessén A. Intravenous nitroglycerin for rapid uterine relaxation.  Acta Obstet Gynecol Scand. 1998;  77 50-53
    CrossrefPubMedGoogle Scholar
  • 20 Smith G, Brien J. Use of nitroglycerin for uterine relaxation.  Obstet Gynecol Surv. 1998;  53 559-564
    CrossrefPubMedGoogle Scholar
  • 21 Magann E F, Cleveland R S, Dockery J R, Chauhan S P, Martin Jr J N, Morrison J C. Acute tocolysis for fetal distress: terbutaline versus magnesium suphate.  Aust N Z J Obstet Gynaecol. 1993;  33 362-364
    PubMedGoogle Scholar

Outi PalomäkiM.D. 

Senior Consultant, Tampere University Hospital, PL 2000, 33521 Tampere, Finland

      >